Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard R Winkelmann

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Expert Opinion on Investigational Drugs|April 23, 2004
American Heart Association scientific sessionsBernhard R Winkelmann
Pharmacogenomics|August 29, 2003
Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questionsBernhard R Winkelmann
Future Cardiology|October 7, 2009
Future cardiology--yet another cardiology journal?Bernhard R Winkelmann
Pharmacogenomics|April 26, 2002
Classification and prediction in pharmacogenetics--context, construction and validationUlrich Mansmann, Bernhard R Winkelmann
European Heart Journal|March 25, 2004
Molecular genetics of myocardial infarction: many genes, more questions than answersGiuseppe Vassalli, Bernhard R Winkelmann
Pharmacogenomics|April 27, 2010
Pharmacogenomics--10 years of progress: a cardiovascular perspectiveBernhard R Winkelmann, David Herrington
Scandinavian Cardiovascular Journal : SCJ|October 3, 2006
Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study)Johannes Ruef, Winfried März, Bernhard R Winkelmann
Biomarkers in Medicine|May 19, 2010
Smoking and atherosclerotic cardiovascular disease: Part I: atherosclerotic disease processBernhard R Winkelmann, Klaus von Holt, Martin Unverdorben
Biomarkers in Medicine|May 19, 2010
Smoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease developmentMartin Unverdorben, Klaus von Holt, Bernhard R Winkelmann
Biomarkers in Medicine|May 19, 2010
Smoking and atherosclerotic cardiovascular disease: part III: functional biomarkers influenced by smokingMartin Unverdorben, Klaus von Holt, Bernhard R Winkelmann
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|April 23, 2004
American Heart Association scientific sessionsBernhard R Winkelmann
Pharmacogenomics|August 29, 2003
Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questionsBernhard R Winkelmann
Future Cardiology|October 7, 2009
Future cardiology--yet another cardiology journal?Bernhard R Winkelmann
Pharmacogenomics|April 26, 2002
Classification and prediction in pharmacogenetics--context, construction and validationUlrich Mansmann, Bernhard R Winkelmann
European Heart Journal|March 25, 2004
Molecular genetics of myocardial infarction: many genes, more questions than answersGiuseppe Vassalli, Bernhard R Winkelmann
Pharmacogenomics|April 27, 2010
Pharmacogenomics--10 years of progress: a cardiovascular perspectiveBernhard R Winkelmann, David Herrington
Scandinavian Cardiovascular Journal : SCJ|October 3, 2006
Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study)Johannes Ruef, Winfried März, Bernhard R Winkelmann
Biomarkers in Medicine|May 19, 2010
Smoking and atherosclerotic cardiovascular disease: Part I: atherosclerotic disease processBernhard R Winkelmann, Klaus von Holt, Martin Unverdorben
Biomarkers in Medicine|May 19, 2010
Smoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease developmentMartin Unverdorben, Klaus von Holt, Bernhard R Winkelmann
Biomarkers in Medicine|May 19, 2010
Smoking and atherosclerotic cardiovascular disease: part III: functional biomarkers influenced by smokingMartin Unverdorben, Klaus von Holt, Bernhard R Winkelmann
Pageof 8